Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
60 studies found for:    tigecycline
Show Display Options
Rank Status Study
1 Recruiting Study of Tigecycline Pharmacokinetics in Patients Undergoing Continuous Renal Replacement Therapy(CRRT)
Conditions: Bacterial Infection;   Critically Ill
Intervention: Drug: Tigecycline
2 Unknown  Effectiveness and Safety of Tigecycline for Therapy of Infections Caused by Multi-Drug Resistant Acinetobacter Baumannii
Condition: Antibiotic Resistant Infection
Intervention: Drug: Tigecycline
3 Active, not recruiting Tygacil Drug Use Investigation
Conditions: Intra-Abdominal Infections;   Skin Disease, Infectious
Intervention: Drug: Tigecycline (Tygacil)
4 Completed Pharmacokinetic Study Of Tigecycline In Adult Subjects With Primary Biliary Cirrhosis
Condition: Liver Cirrhosis, Biliary
Intervention: Drug: tigecycline
5 Completed Pharmacokinetics Of Tigecycline In Morbidly Obese Subjects
Condition: Obesity
Intervention: Drug: Tigecycline
6 Completed Open Label Non-comparative Clinical Trial of Tigecycline in Patients With Catheter Infection
Condition: Staphylococcal Infections
Intervention: Drug: Tigecycline
7 Completed Safety Study Evaluating Intravenous Infusions of Tigecycline to Treat Acute Myeloid Leukemia
Condition: Acute Myeloid Leukemia
Intervention: Drug: Tigecycline
8 Recruiting Effect Study of Tigecycline to Treat Severe Sepsis and Septic Shock
Condition: Abdominal Infection
Interventions: Drug: glycopeptide plus carbapenem;   Drug: Haizheng Li Xing ® plus tazocin ®
9 Completed
Has Results
Post-Authorization Study Evaluating Safety Of Tigecycline
Conditions: Intra-Abdominal Infections;   Skin Disease, Infectious;   Soft Tissues Infections
Intervention: Drug: Tigecycline
10 Completed
Has Results
Pharmacokinetics and Safety of Tigecycline in the Treatment of Clostridium Difficile Associated Diarrhea (CDAD)
Conditions: Diarrhea;   Clostridium Difficile
Intervention: Drug: Tigecycline
11 Unknown  Tigecycline for Treatment of Rapidly Growing Mycobacteria
Conditions: Mycobacterium Abscessus Lung Disease;   Rapidly Growing Mycobacterial Lung Disease
Intervention: Drug: Tigecycline
12 Completed
Has Results
Study Evaluating The Safety And Effectiveness In Subjects With Tigecycline Treatment
Conditions: Complicated Skin and Skin Structure Infections;   Complicated Intra-abdominal Infections;   Community-Acquired Bacterial Pneumonia
Intervention: Drug: tigecycline
13 Completed Study Evaluating the Pharmacokinetics of Tigecycline in Human Bone
Condition: Healthy Subjects
Intervention: Drug: Tigecycline
14 Completed Study To Evaluate The Effect Of Single Intravenous Doses Of Tigecycline On QTc Intervals In Healthy Subjects
Condition: Healthy
Interventions: Drug: tigecycline;   Drug: moxifloxacin;   Drug: 100 mL 0.9% Sodium Chloride intravenous;   Drug: placebo
15 Completed
Has Results
A Pharmacovigilance Evaluation And Assessment Of The Prescribing Practice For Tygacil In Usual Health Care Setting
Condition: Infection
Intervention: Drug: tigecycline
16 Withdrawn Study Evaluating Tigecycline Versus Clindamycin Or Vancomycin On Complicated Skin And Skin Structure Infections Including Those Due To Methicillin-Resistant Staphylococcus Aureus (MRSA) In Pediatric Subjects
Conditions: Skin Diseases;   Infection
Interventions: Drug: Tigecycline;   Drug: Clindamycin (or Vancomycin if needed)
17 Withdrawn Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired Pneumonia
Conditions: Community Acquired Bacterial Pneumonia;   Complicated Intra-Abdominal Infection
Interventions: Drug: Tigecycline;   Drug: cIAI: Ceftriaxone with metronidazole, plus if applicable aminoglycoside;   Drug: CAP: Ceftriaxone, plus if applicable oral clarithromycin
18 Withdrawn Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired Pneumonia
Conditions: Community Acquired Bacterial Pneumonia;   Complicated Intra-Abdominal Infection
Interventions: Drug: Tigecycline;   Drug: cIAI: Ceftriaxone with metronidazole, plus if applicable aminoglycoside;   Drug: CAP: Ceftriaxone, plus if applicable oral clarithromycin
19 Completed Study Evaluating the Safety and Efficacy of Tigecycline in Hospitalized Patients With cSSSI
Condition: Skin Diseases, Infectious
Intervention: Drug: Tigecycline
20 Completed Study Evaluating the Safety and Efficacy of Tigecycline in Hospitalized Patients With cIAI
Condition: Abdominal Abscess
Intervention: Drug: tigecycline

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.